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Ethnopharmacological relevance: Pluchea sagittalis, an herbaceous plantwidely distributed in South Amer-
ica, is used in folk medicine for the treatment of digestive diseases and inﬂammation.
Aim of the study: This study was designed to investigate the antinociceptive and gastroprotective effects
of the ethanolic extract (EE) of aerial parts from Pluchea sagittalis in rodents.
Materials and methods: The antinociceptive effects of EE was evaluated in mice after oral administration
in chemical tests (acetic-acid, glutamate and formalin) or by biting behavior following intrathecal admin-
istration of cytokines such as interleukin-1beta (IL-1) and tumor necrosis factor-alpha (TNF-) in mice.
Furthermore, ratswere treatedwith EE and subsequently exposed to acute gastric lesions induced by 80%
ethanol. Afterwards the gastric lesion extension and the mucus levels of gastric mucosa were measured.
Results: The oral administration of EE showed a dose-dependent inhibition of acetic acid-induced abdom-
inal constrictions and glutamate-induced pain inmice,with ID50 values of 624.0 (523.0–746.0)mg/kg and
368.0 (216.0–628.0)mg/kg, respectively. In the formalin test, the EE also produced signiﬁcant inhibition
of the inﬂammatory phase, with an ID50 value of 411.0 (183.0–721.0) mg/kg; however, it was ineffective
in the neurogenic phase caused by formalin. In addition, oral treatment with EE caused a signiﬁcant inhi-
bition of biting behavior induced by i.t. injection of interleukin-1 (IL-1) and tumor necrosis factor-
(TNF-). The antinociception caused by the EE (300mg/kg, p.o.) was not reversed by naloxone (1mg/kg,
i.p.) when assessed in the acetic acidwrithing test. The EE (300–1000mg/kg, p.o.) did not affect themotor
coordination of animals in an open-ﬁeld model. Oral treatment with the EE protected rats against gastric
lesions induced by ethanol, with an ID50 value of 55.0 (46.6–64.9)mg/kg, and increased the mucus levels
of gastric mucosa to levels found in the non-lesioned group.
Conclusions: Themechanismbywhich the extract produced antinociception still remains unclear, but this
effect seems to be primarily related to the modulation or inhibition of the action of pro-inﬂammatory
mediators. Furthermore, these data support, at least in part, the ethnomedical use of Pluchea sagittalis.
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1. Introduction
The plants belonging to the genus Pluchea, amember of the fam-
ily Asteraceae, consist of approximately 90 species that grow in
several countries in South America. These herbaceous plants are
widely found in Paraguay, Argentina and Brazil. Pluchea sagittalis
(Lam.) is popularly known as “Lucera,” “Yerba Lucero” or “Quitoc.”
Extracts or infusions from aerial parts of the plant have been used
in different countries in traditional medicine to treat several dis-
d. All rights reserved.
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rders, including inﬂammation, digestive diseases, diarrhea and
olorous processes (Anderberg, 1994).
Some studies have shown that other species of this genus
luchea lanceolata have anti-inﬂammatory and immunosuppres-
iveactivities (Chawlaet al., 1991;Bhagwatet al., 2010). In addition,
he methanolic fraction of a chloroform extract of roots from
luchea indica showed anti-ulcer and anti-inﬂammatory activi-
ies as well as the inhibition of protein exudation and leukocyte
igration through the involvement of the 5-lipoxigenase pathway
Sen and Nag-Chaudhuri, 1991; Sen et al., 1993). Pharmacolog-
cal studies demonstrated that aqueous and dichloromethane
xtracts obtained from Pluchea sagittalis have a wide spectrum
f anti-inﬂammatory activity, correlating with the reduction of
ree radicals (Pérez-Garcia et al., 1996). Furthermore, Pérez-Garcia
t al. (2001) showed a signiﬁcant inhibition of reactive nitrogen
pecies (RNS) and heat shock protein (hsp) production in human
eutrophils using the dichloromethane extract of Pluchea sagittalis.
hytochemical studies have also shown that triterpene taraxasteryl
cetate is an important active compound of the extract that has a
opical anti-inﬂammatory effect, similar to the dichloromethane
xtract of Pluchea sagittalis. Furthermore, triterpene taraxasteryl
cetate inhibited the production of reactive oxygen species (ROS)
nd reactive nitrogen species (RNS) in stimulated human neu-
rophils (Pérez-Garcia et al., 2004). In addition, studies have
emonstrated that the ethanolic extract of Pluchea quitoc DC
xhibits an anti-inﬂammatory effect against carrageenan-induced
aw edema and croton oil-induced ear edema and produces
ntinociceptive actionagainst acetic acid-inducedvisceral nocicep-
ionand formalin-induced lickingaswell as ina tail ﬂick test (Barros
t al., 2006).
Therefore, considering the therapeutic properties attributed to
his plant and the anti-inﬂammatory effects demonstrated by pre-
ious studies, we investigated the antinociceptive action of the EE
f aerial parts from Pluchea sagittalis on several models of nocicep-
ion in mice, and we also investigated the possible involvement of
ro-inﬂammatory cytokines, IL-1 and TNF-, on its antinocicep-
ive action. In addition, we veriﬁed the gastroprotective effect of EE
n gastric lesions induced by ethanol.
. Materials and methods
.1. Preparation of the ethanolic extract of Pluchea sagittalis
Pluchea sagittalis was collected in Asunción, Paraguay, in July
006. A voucher specimen has been deposited at the Herbarium of
he Faculty of Chemical Sciences, Universidad Nacional de Asun-
ión, Paraguay, under number 3464.
After collecting thematerial, the dry aerial parts of Pluchea sagit-
alis (600g) were powdered and extracted with ethanol at room
emperature for approximately twoweeks. After the plantmaterial
as ﬁltered and the residue rejected, being the solvent evaporated
nder reduced pressure to obtain the crude ethanolic extract. Addi-
ionally, the Pluchea sagittalis sample used in our study was tested
or the presence of ﬂavonoids, tannins, saponins and terpenes by
hin-layer chromatography using different solvent systems and
evealers (Harborne, 1984).
.2. Animals
Experiments were conducted using adult male Swiss mice
25–35g) and male Wistar rats (200–250g) that were housed at
2±2◦C under a 12-h light/dark cycle (lights on at 06:00) and with
ree access to food andwater. Animalswere habituated to the labo-
atory conditions for at least two hours before testing. Experiments
ere performed between 09:00 and 16:00. Each animal was usedarmacology 135 (2011) 603–609
only once during the study. The experiments were approved by the
Ethics Committee for Animal Research of the Federal University of
Santa Catarina and were performed in accordance with the current
guidelines for the care of laboratory animals and the ethical guide-
lines for investigations of experimental pain on conscious animals
(Zimmermann, 1983). The number of animals and the intensity of
the noxious stimuli were theminimumnecessary to obtain reliable
data.
2.3. Abdominal constriction induced by acetic acid
The procedure used for the acetic acid-induced abdominal con-
striction was similar to one previously described (Santos et al.,
2005) and resulted in the contraction of the abdominal muscle
together with a stretching of the hind limbs in response to an
intraperitoneal injection of acetic acid (0.6%) at the time of the
test. Animals were pretreated with EE (3–1000mg/kg, p.o.) 60min
before testing. Control animals received a similar volume of the
appropriate vehicle. After the challenge, themicewere individually
placed into glass cylinders of 20 cm diameter, and the abdominal
constrictions were cumulatively counted over 20min.
2.4. Nociception induced by glutamate
In an attempt to provide more direct evidence concerning
the possible interaction of EE with the glutamatergic system, we
separately investigated whether EE would be able to antagonize
glutamate-induced licking in the mouse paw. The procedure used
was similar to one previously described (Meotti et al., 2005). A
volume of 20L of glutamate (20mol/paw) was injected intra-
plantarly in the ventral surface of the right hind paw. Animals
were observed individually for 15min following glutamate injec-
tion. The amount of time spent licking the injected paw was timed
with a chronometer andwas considered to be indicative of nocicep-
tion. Mice were orally treated with EE (10–1000mg/kg) or vehicle
(10mL/kg) 60min before glutamate injection.
2.5. Nociception induced by formalin
The procedure used was essentially the same as previously
described (Santos and Calixto, 1997; Santos et al., 1999). Mice
received 20L of a 2.5% formalin solution (0.92% formaldehyde)
in saline and were injected intraplantarly in the ventral surface of
the right hindpaw. Animals were observed from 0 to 5min (neuro-
genic phase) and 15 to 30min (inﬂammatory phase), and the time
spent licking the injected paw was recorded with a chronometer
and considered to be indicative of nociception. Mice received EE
(10–1000mg/kg, p.o.) 60min before the formalin injection. Con-
trol animals were treated with vehicle (10mL/kg, p.o.). Following
the intraplantar injection of formalin, the mice were immediately
placed in a glass cylinder (20 cmdiameter), and the time spent lick-
ing the injected paw was recorded for both the early and late phase
of this model.
2.6. Analysis of the possible mechanism of action of Pluchea
sagittalis
2.6.1. Involvement of the opioid system
To investigate the possible participation of the opioid system in
the antinociceptive effect of EE, mice were pretreated with nalox-
one (a nonselective opioid receptor antagonist, 1mg/kg, i.p.), and
after 20min, the animals received an injection of EE (300mg/kg,
p.o.), morphine (2.5mg/kg, s.c.) or vehicle (10mL/kg, p.o.). Other
groups were pretreated with vehicle and received EE, morphine, or
vehicleafter20min.After60min, they receivedanacetic acid (0.6%)
hnopharmacology 135 (2011) 603–609 605
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Fig. 1. Effect of EE of Pluchea sagittalis (3–1000mg/kg, p.o.) on abdominal constric-S.M. Figueredo et al. / Journal of Et
njection, and the abdominal constrictions were counted cumula-
ively over a period of 20min.
.6.2. Biting response induced by pro-inﬂammatory cytokines
We also investigated the properties of EE against pro-
nﬂammatory cytokine (IL-1 and TNF-)-induced biting behavior
n mice. Animals received EE (300mg/kg, p.o.) or indomethacin
10mg/kg, i.p.) 1h or 30min after they received an intrathe-
al injection of 5L of pro-inﬂammatory cytokines (TNF-,
.1 pmol/site or IL-1, 1 pmol/site) or vehicle solution. Injections
eregivenaccording themethoddescribedpreviously (Hyldenand
ilcox, 1980) and for a period of 5 s. Animals were observed indi-
idually for 15min following intrathecal injection. The amount of
ime spent biting the paws, tail and posterior portion of the body
as timed and was considered to be indicative of nociception.
.6.3. Evaluation of locomotor activity
The open-ﬁeld test was used to exclude the possibility that the
ntinociceptive action of EE could be related to non-speciﬁc distur-
ances in the locomotor activity of the animals. The ambulatory
ehavior was assessed in an open-ﬁeld test as described previ-
usly (Rodrigues et al., 2002). The apparatus consisted of a wooden
ox measuring 40 cm×60 cm×50 cm. The ﬂoor of the arena was
ivided into 12 equal squares, and the number of squares crossed
ith all paws crossing was counted in a 6-min session. Mice were
reatedwith EE (300–1000mg/kg, p.o.) or vehicle 60min before the
est.
.7. Induction of acute gastric lesions
The possible gastroprotective effects of EE were investigated
n acute lesions induced by ethanol in rats. Animals were orally
reated with vehicle (0.1mL/100g), EE (30–300mg/kg) or omepra-
ole (40mg/kg) 60min before the administration of 80% ethanol
0.5mL/200g, p.o.). Animals were sacriﬁced by cervical disloca-
ion 1h after treatment (Robert et al., 1979). The stomachs were
emoved, and gastric lesion extension was measured as the total
njured area (mm2) = length (mm)×width (mm) of injury as previ-
usly described (Baggio et al., 2007). Finally, the glandular mucosa
as weighed and used for mucus determination.
.8. Determination of gastric mucus
The gastric tissues were immediately transferred to 0.1% alcian
lue solution prepared in 0.16mM sucrose and 50mM sodium
cetate (pH 5.0) and stained for 2h at room temperature. Next,
he gastric mucosa was rinsed twice with 250mM sucrose solu-
ion for 15 and 45min, and the dye complexed with the gastric
ucus was extracted with 500mM magnesium chloride solution
or 2h. The extractwas thenmixedwith an equal volume of diethyl
ther and was centrifuged at 3600 rpm for 10min. Absorbance was
etermined at 598nm. The amount of mucus was calculated using
tandard curves of alcian blue (6.25–100.0g) (Corne et al., 1974).
.9. Drugs
The following substances were used: acetic acid, formalin and
orphine hydrochloride (Merck, Darmstadt, Germany); alcian
lue, l-glutamic acid, indomethacin and naloxone hydrochloride
Sigma Chemical Co., St. Louis, USA), interleukin-1 (IL-1) and
umor necroses factor- (TNF-) (R&D Systems, Minneapolis, USA)
nd Tween 80 (Merck, A.G., Darmstadt, Germany). All drugs were
issolved in saline solution (0.9% NaCl) with the exception of
thanolic extract, which was dissolved in saline plus Tween 80,
nd indomethacin, which was dissolved in saline with 5% DMSO.
he ﬁnal concentration of Tween 80 did not exceed 5% and did nottions induced by acetic acid. Each column represents the mean± S.E.M. (n=6–8).
Control values (C) indicate the administration of vehicle (saline and Tween 80,
10mL/kg), and the asterisks denote the signiﬁcance levels when compared with
the control group; **p<0.01.
cause any effect per se. All control groups of animals received the
vehicle used to dissolve the ethanolic extract.
2.10. Statistical analysis
The resultswere presented asmeans± S.E.M. except for the ID50
values (i.e., the dose of extract necessary to reduce the nocicep-
tive response by 50% relative to the control value), which were
reported as geometric means accompanied by their respective
95% conﬁdence limits. The ID50 value was determined by nonlin-
ear regression from individual experiments using linear regression
GraphPad software (GraphPad software, San Diego, CA, USA). The
statistical signiﬁcance of differences between groups was detected
byANOVA followedbyNewman–Keuls’ test. P-values less than0.05
(P<0.05) were considered to be indicative of signiﬁcance.
3. Results
3.1. Acetic acid-induced abdominal constrictions
The results depicted in Fig. 1 show that the oral adminis-
tration of EE 60min prior to testing produced a dose-related
inhibition of acetic acid-induced abdominal constrictions in mice
when compared to the control group, with ID50 values of 624.0
(523.0–746.0)mg/kg and an inhibition of 67±6%.
3.2. Glutamate-induced nociception
After 60min, oral treatment with EE caused a signiﬁcant inhi-
bition of glutamate-induced nociception, with an ID50 value of
368.0 (216.0–628.0) mg/kg and an inhibition of 83±4% at dose of
1000mg/kg orally (Fig. 2).
3.3. Formalin-induced nociception
The administration of EE (10–1000mg/kg, p.o.) did not inhibit
the neurogenic phase (0–5min) but reduced the inﬂammatory
phase (15–30min) of formalin-induced licking, with an ID50 value
of 411.0 (183.0–721.0)mg/kg and an inhibition of 88±12% at dose
of 1000mg/kg orally (Fig. 3A and B).3.4. Involvement of the opioid system
The results presented in Fig. 4 show that the pre-treatment of
mice with naloxone (1mg/kg, i.p., a non-selective opioid recep-
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Fig. 2. Effect of EE of Pluchea sagittalis (10–1000mg/kg, p.o.) on glutamate-induced
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Fig. 4. Effect of pre-treatment of animals with naloxone (1mg/kg, i.p.) on the
antinociceptive proﬁles of EE of Pluchea sagittalis (300mg/kg) and morphine
(2.5mg/kg, s.c.) against acetic acid-induced writhing in mice. Each column rep-
resents the mean± S.E.M. (n=6–8). Control values (C) indicate the administration
of vehicle (saline and Tween 80, 10mL/kg), and the asterisks denote the signiﬁ-
cance levels when compared with the control group; ***p<0.001; compared to the
morphine group, #p<0.05.
Fig. 5. EffectofEEofPluchea sagittalis (300mg/kg,p.o.) and indomethacin (10mg/kg,
i.p.) on the biting response caused by intrathecal injection of IL-1 and TNF- ago-
F
t
cicking in mice. Each column represents the mean± S.E.M. (n=6–8). Control values
C) indicate the administration of vehicle (saline and Tween 80, 10mL/kg), and the
sterisks denote the signiﬁcance levels when compared with the control group;
*p<0.01 and ***p<0.001.
or antagonist) given 30min before the test did not reverse the
ntinociception caused by EE (300mg/kg, p.o.) but completely
eversed the antinociception caused by morphine (2.5mg/kg, s.c.)
hen analyzed against acetic acid-induced pain.
.5. Involvement of pro-inﬂammatory cytokines
Intrathecal administrationof IL-1andTNF- causedsigniﬁcant
iting behavior in mice. EE (300mg/kg, p.o.) inhibited the biting
esponses induced by IL-1 and TNF-with respective inhibitions
f 71±7% and 97±6%. In contrast, indomethacin (10mg/kg, i.p.)
as able to reduce only the nociception caused by IL-1, with an
nhibition of 57±10% (Fig. 5).
.6. Evaluation of locomotor activity
The treatment with EE (300–1000mg/kg, p.o.) did not alter
he ambulation of mice in the open-ﬁeld test. The means± S.E.M.
f crossing numbers 1h after administration were 80.0±6.4,
3.0±7.3 and 64.3±5.6 for the control group and groups receiving
00 and 1000mg/kg of EE, respectively.
.7. Effects on gastric injuryThe EE treatment (30, 100 or 300mg/kg, p.o.) caused a dose-
elated reduction in gastric lesions induced by 80% ethanol,
ecreasing the ulcer area mainly at doses of 100 and 300mg/kg
Fig. 6A), with a mean ID50 value of 55.0 (46.6–64.9)mg/kg
injured control group value =150.4±12.8mm2) and an inhibition
ig. 3. Effect of EE of Pluchea sagittalis (10–1000mg/kg, p.o.) on the ﬁrst phase (A) and t
he mean± S.E.M. (n=6–8). Control values (C) indicate the administration of vehicle (sali
ompared with the control group; **p<0.01.nists in mice. Each column represents the mean± S.E.M. (n=6–8). Control values
(C) indicate the administration of vehicle (saline and Tween 80, 10mL/kg), and the
asterisks denote the signiﬁcance levels when compared with the control group;
**p<0.01 and ***p<0.001.
of 90±2%at 300mg/kg. Thepositive control of the test, omeprazole
(40mg/kg, p.o.), reduced the gastric lesions induced by ethanol by
52±8%.
The gastric wall mucus was quantiﬁed in the ethanol-induced
gastric ulcermodel. The amount of gastricwallmucus in the injured
control (C) was decreased by 49±5% when compared to the non-
he second phase (B) of formalin-induced licking in mice. Each column represents
ne and Tween 80, 10mL/kg), and the asterisks denote the signiﬁcance levels when
S.M. Figueredo et al. / Journal of Ethnopharmacology 135 (2011) 603–609 607
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eig. 6. Effect of EE of Pluchea sagittalis (30–300mg/kg, p.o.) on gastric lesions induc
he mean± S.E.M. (n=6–8). Control values (C) indicate the administration of vehicl
ompared with the control group, **p<0.05 and ***p<0.001.
esioned group (NL: 154.6±23.9g alcian blue/g of tissue). The
dministration of EE (300mg/kg, p.o.) increased the amount of
ucus to 148.6±11.7g alcian blue/g of tissue when compared to
he injured control (C: 78.9±8.4g alcianblue/g of tissue) (Fig. 6B).
.8. Phytochemical analysis
The phytochemical analysis of Pluchea sagittalis indicated the
ntense presence of terpenoids and small presence of ﬂavonoids.
. Discussion
The plants of genus Pluchea are used in folk medicine for
he treatment of several conditions, including disorders of the
owel and kidney. In addition to these medicinal uses, there are
eports showing anti-microbial and hypoglycemic properties of
ome Pluchea species (Sen et al., 2002).
Chemical studies carried out with some species belonging
o the genus Pluchea have demonstrated the presence of many
onstituents, such as stigmasterol,-amiryn, taraxasteryl, pseudo-
araxasteryl, monoterpens, lignin glycosides and ﬂavonoids
Guilhon and Muller, 1996; Vera et al., 2008). Several biological
ffects of Pluchea sagittalis extract and its isolated compound have
een demonstrated. Pérez-Garcia and colleagues (2004) demon-
trated the anti-inﬂammatory effects of a dichloromethane extract
f Pluchea sagittalis and triterpene taraxasteryl acetate in rat hind
aw-edema. The anti-inﬂammatory action of this extract has been
ttributed to the inhibition of ROS, RNS and Hsp72 synthesis on
timulated neutrophils (Pérez-Garcia et al., 2004).
In accordance with these ﬁndings, this work shows for the ﬁrst
ime that the EE of Pluchea sagittalis when given orally can also
resent antinociceptive effects. The results demonstrate that the
E produced a dose-related inhibition of the number of abdominal
onstrictions elicited by acetic acid, a typical model used to search
or new drugs with analgesic and anti-inﬂammatory properties
Koster et al., 1959; Le Bars et al., 2001). Its antinociceptive effects
ould occur via peripheral or central sites of action. It has been sug-
ested that acetic acid acts by releasing endogenous inﬂammatory
ediators of the nociceptive neurons (Collier et al., 1968), such as
radykinin, prostaglandins and pro-inﬂammatory cytokines, when
njected intraperitoneally (Ribeiro et al., 2000; Ikeda et al., 2001).
he main cytokines involved in nociception induced by acetic acid
re TNF-, interleukin-1 and interleukin 8, and they are released
rom resident peritoneal macrophages and mast cells (Ribeiro et
l., 2000). The concentration of glutamate and aspartate in the cere-
rospinal ﬂuidwas increased after the injection of acetic acid (Feng
t al., 2003). Furthermore, this test is sensitive tonon-steroidal anti-
nﬂammatory drugs (NSAIDs), narcotics and other centrally acting
rugs (Collier et al., 1968; Santos et al., 1998).
Oral administration of the EE also showed antinociceptive
ffects in the inﬂammatory phase (late phase) of formalin-induced80% ethanol (A) and the gastric mucus amount (B) in rats. Each column represents
ne and Tween 80, 10mL/kg), and the asterisks denote the signiﬁcance levels when
nociception but did not inhibit the neurogenic phase (early phase).
Inﬂammatory pain is a consequence of the increase in the spinal
levels of different mediators, such as PGE2, excitatory amino
acids, nitric oxide, tachykinins and kinins. Furthermore, functional
changes in the dorsal horn of the spinal cord are produced by
inﬂammatory pain (Malmberg and Yaksh, 1992; Tjolsen et al.,
1992; Santos and Calixto, 1997). The present results demonstrate
that systemic treatment of mice with EE causes signiﬁcant and
dose-dependent antinociception against glutamate-induced noci-
ception. It is known that glutamate is the main excitatory amino
acid in pain transmission. Therefore, substances capable of block-
ing either iGluRs (ionotropic glutamate receptors) or mGluRs
(metabotropic glutamate receptors) may exhibit antinociceptive
effects in several mammalian species (Neugebauer and Carlton,
2002). Here, we observed that EE did not alter locomotor activity
in the doses that caused signiﬁcant antinociception.
The pro-inﬂammatory cytokines are also involved in the mod-
ulation of nociceptive processes. Cytokines such as TNF- and
IL-1may induce nociceptive behavior when administered by the
intrathecal route. As demonstrated by Cumiskey and colleagues
(2007), after the injection of TNF-alpha, glutamate may be released
by nerve terminals and act on glutamate receptors to induce noci-
ception. Inaddition, this activationof glutamate receptors increases
the calcium inﬂux, activating kinases and mitogen-activated
proteins kinases (Pickering et al., 2005). Thus, glutamatergic trans-
mission is involved in nociception induced by pro-inﬂammatory
cytokines. For this reason, we investigated the effect of EE against
the TNF- and IL-1-induced nociceptive responses in mice (Choi
et al., 2003). This study also showed that orally administered EE
strongly inhibited the biting response caused by the i.t. injec-
tion of cytokines IL-1 and TNF-. We used indomethacin, a
non-steroidal anti-inﬂammatory drug (NSAID), to compare and
evaluate the inhibition of pro-inﬂammatory cytokines. Our results
showed that the EE effect was similar to indomethacin in inhibit-
ing the biting response caused by IL-1. The binding of IL-1 to its
receptor IL-1RI actives tyrosine kinases and is PKC calcium inde-
pendent (Obreja et al., 2002), which could explain, in part, the
antinociception caused by this EE. Another interesting result of this
study was that EE completely inhibited TNF--induced nocicep-
tion. At the same time, indomethacin was ineffective against the
biting response caused by TNF-. Previous reports show that TNF-
-induced nociception involves the phosphorylation of the p38
protein (Schäfers et al., 2003). Thus, these results suggested that
EE has anti-inﬂammatory effect more potent than indomethacin in
these models.
In the next step, we investigated the possible involvement of
the opioid system on the antinociceptive effect of EE, considering
thatmany plants have an antinociceptive activity linked to this sys-
tem. Our data also demonstrate that the central opioid system is
probably not involved in the antinociception produced by EE. This
assertion is supported by the demonstration that the treatment of
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nimals with naloxone (a non-selective opioid receptor antagonist
hat penetrates the blood–brain barrier) at a dose that produced
o signiﬁcant effect on acetic acid-induced constrictions did not
everse the antinociceptive effect caused by EE.
Conventional NSAIDs inhibit both COX-1 and COX-2 at stan-
ard anti-inﬂammatory doses, and this dual inhibition may lead
o a number of side effects, particularly gastrointestinal ulcera-
ion (Wallace et al., 2000; Tanaka et al., 2001). For this reason, we
ested EE against gastric lesions induced by ethanol and observed
hat EE possess desirable gastroprotective activity. Ethanol is a
ell-known necrotizing agent that destroys the mucus barrier
Hirschowitz, 1983), increases vascular permeability (Szabo et al.,
985) and decreases non-proteic sulfhydryl groups (NP-SH) of
he gastric mucosa (Repetto and Llesuy, 2002; Siegmund, 2003).
he mucus, which continuously coats the gastric mucosa, pre-
ents injuries from luminal acid, bacteria and noxious agents
Chen et al., 2005). In our experiments, we observed that one
f these protective factors was enhanced by treatment with EE,
hich indicates that the mechanism of protection of this extract
gainst ethanol injury may be related to this important mecha-
ism of cytoprotection. In addition, EE is devoid of gastrointestinal
dverse effects, and in contrast, seems to exert a protective gas-
ric effect. Thus, it can have considerable advantages compared to
ndomethacin.
The phytochemical components responsible for Pluchea sagit-
alis antinociceptive effect are unknown, but preliminary studies
emonstrated the presence of sesquiterpenoids 3a-(2,3-epoxy-
-methylbutyryloxy)-4a-formoxy-11-hydroxy-6,7-dehydro-
udesman-8-one and 3a-(2,3-epoxy-2-methylbutyryloxy)-
a,7a,11-trihydroxyeudesman-8-one) in this plant (Vera et al.,
008). Moreover, our preliminary phytochemical analysis of
luchea sagittalis indicated the presence of terpenoids and small
resence of ﬂavonoids. These data suggest that terpenoids and
avonoids may be contributed to antinociceptive effect caused by
E of Pluchea sagittalis.
In conclusion, the present study demonstrates that the EE of
luchea sagittalis exerts dose-related antinociceptive action against
cetic acid, formalin and glutamate nociceptive models of pain in
ice at a dose that does not interferewith locomotor activity. Addi-
ionally, the antinociceptive action of Pluchea sagittalis is related to
echanisms that depend on TNF- and IL-1 and do not depend
n the opioid system. The mechanism by which the EE produces
ntinociception still remains unclear, but we are continuing phar-
acological and chemical studies to characterize themechanism(s)
esponsible for the antinociceptive action and to identify the effect
f the active principles present in Pluchea sagittalis. These ﬁndings
upport, at least partially, the use of Pluchea sagittalis in traditional
edicine.
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